Dehydroabietic acid (DAA) is a food-derived diterpene that inhibits Epstein-Barr virus early antigen (EBV-EA) activation. Research indicates its potential in metabolic studies, where it has been shown in animal models to reduce plasma glucose, insulin, and triglyceride levels, and to exhibit anti-secretory effects.